Immunochromatographic test strip and detection method using immunochromatography for detecting object in red blood cell-containing sample

US10416156B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10416156-B2
Application numberUS-201615363895-A
CountryUS
Kind codeB2
Filing dateNov 29, 2016
Priority dateMar 30, 2012
Publication dateSep 17, 2019
Grant dateSep 17, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A problem to be solved by the present invention is to provide an immunochromatographic test strip and a detection method using immunochromatography avoiding aggregation of colloidal gold conjugates while red blood cells in whole blood are agglutinated and then separated and removed in the case of using polybrene as a blood-agglutinating agent and the colloidal gold conjugates as a detection reagent. To solve the problem, the present inventers reviewed a past reagent configuration itself from a completely different viewpoint rather than selecting type and amount of polyanions and, as a result of extensive study on each element, the inventers surprisingly found that aggregation of colloidal gold can be suppressed by using a certain buffer solution without using neutralization by polyanions.

First claim

Opening claim text (preview).

The invention claimed is: 1. An immunochromatographic detection method, comprising the steps of: (A) supplying a sample to a sample-supply portion of a test strip, said test strip comprising a membrane, said membrane comprising a porous body, which comprises a sample-supply portion and a spreading portion, wherein the sample-supply portion is upstream from the spreading portion, wherein a conjugate comprising a colloidal gold sensitized with an anti-analyte antibody is retained in a dissoluble manner in a conjugate-retaining part of the spreading portion, and an antibody is immobilized in a detecting part of the spreading portion, which is downstream from the conjugate-retaining part, wherein a Tris buffer solution is contained in the sample-supply portion or the conjugate-retaining part of the spreading portion in a dry state, and wherein the test strip does not comprise a polyanion as a neutralizer for neutralizing a cation of hexadimethrine bromide; (B) agglutinating red blood cells in the sample through contact between the hexadimethrine bromide and the sample in the sample-supply portion or in the upstream of the sample-supply portion; (C) separating and removing aggregates acquired at step (B) from the sample; (D) bringing a sample component acquired at step (C), after separation and removal of the aggregates, into contact with the colloidal gold-containing conjugate, step (D) being performed in the presence of the Tris buffer solution component; and (E) detecting a complex of the analyte in the sample component and the conjugate acquired at the step (D) with the antibody immobilized in the detecting part. 2. The detection method of claim 1 , wherein the sample-supply portion comprises hexadimethrine bromide. 3. The detection method of claim 1 , wherein the sample-supply portion contains the Tris buffer solution component for suppressing aggregation of the conjugate due to the hexadimethrine bromide. 4. The detection method of claim 2 , wherein the sample-supply portion contains the Tris buffer solution component for suppressing aggregation of the conjugate due to the hexadimethrine bromide. 5. The detection method of claim 1 , wherein the sample-supply portion comprises glass fiber. 6. The detection method of claim 1 , wherein the sample-supply portion is a sample pad and the conjugate-retaining part of the spreading portion is a conjugate pad.

Assignees

Inventors

Classifications

  • Nanoparticles · CPC title

  • Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding · CPC title

  • Test strips · CPC title

  • Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding · CPC title

  • Metal or metal coated · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10416156B2 cover?
A problem to be solved by the present invention is to provide an immunochromatographic test strip and a detection method using immunochromatography avoiding aggregation of colloidal gold conjugates while red blood cells in whole blood are agglutinated and then separated and removed in the case of using polybrene as a blood-agglutinating agent and the colloidal gold conjugates as a detection rea…
Who is the assignee on this patent?
Sekisui Medical Co Ltd
What technology area does this patent fall under?
Primary CPC classification G01N33/54393. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Sep 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).